Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition.

about

Continuum of care in the treatment of ST-segment elevation myocardial infarction (STEMI): importance of platelet and coagulation inhibition.

Item

http://www.wikidata.org/entity/Q37226395

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Continuum of care in the treat ...... et and coagulation inhibition.

@en

Continuum of care in the treatment of ST-segment elevation myocardial infarction

@nl

type

Item

label

Continuum of care in the treat ...... et and coagulation inhibition.

@en

Continuum of care in the treatment of ST-segment elevation myocardial infarction

@nl

prefLabel

Continuum of care in the treat ...... et and coagulation inhibition.

@en

Continuum of care in the treatment of ST-segment elevation myocardial infarction

@nl

P1476

Continuum of care in the treat ...... et and coagulation inhibition.

@en

P2093

Chadwick D Miller

http://www.w3.org/2001/XMLSchema#string

George Kikano

http://www.w3.org/2001/XMLSchema#string

James W Hoekstra

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Get with the guidelines for cardiovascular secondary prevention: pilot results

Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction

NRMI and current treatment patterns for ST-elevation myocardial infarction

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

P304

67-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2008.07.1793

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Matthew T Roe

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18654071

http://www.w3.org/2001/XMLSchema#string

P921

Aat atak